We are very excited to announce that FUSE-AI is now officially a member of the World Trade Center (WTC) Twente in the Netherlands. This membership opens up numerous opportunities that will be essential to our global growth and business development.

Am 9. September 2024 spricht Matthias Steffen als Partner der T-Systems Schweiz auf dem Business Day der Zukunftsarena 2024 in Bern. Sein Thema in der Sektion „KI – Game Changer in Diagnostik und Therapie“ ist die „Erkennung von Prostatakrebs mit Hilfe von künstlicher Intelligenz“.

With the AI solution for radiology, Prostate.Carcinoma.ai, FUSE-AI has been awarded in the "Health AI" category! The „KI Innovation Award“ recognizes outstanding achievements in the development and implementation of artificial intelligence technologies. Founded in 2019, FUSE-AI is known for its innovative medical AI software that supports radiological practice.

The Integrating the Healthcare Enterprise ("IHE") is an initiative by healthcare professionals and industry to improve the way computer systems in healthcare share information. IHE develops guidelines and supports a testing process and other activities to encourage the implementation of standards to enable communication among such systems. FUSE-AI has joined this initiative.

On June 27, 2024, Matthias Steffen and Juri Rohde were guests at Oost NL, an economic development agency in the eastern Netherlands. FUSE-AI intends to operate internationally and has become aware of Oost-NL in this context.

With our AI solution “Prostate.Carcinoma.ai”, we have reached the final round of two prestigious competitions: the AI Innovation 2024 and the KPMG Venture Champion Award. The AI Innovation Award, presented by the AI Federal Association Germany, recognizes pioneering achievements of companies. The focus is not only on the development of the company's own AI solution but also on its sustainable impact on the industry and society overall.

Lots of impetus for the use of AI in medicine at the presentation
On May 29, the ‘Day of Innovation and Research’ took place for the second time at the Kantonsspital Aarau KSA, Switzerland - focusing this time on the topic of “Artificial Intelligence in Medicine”.

FUSE-AI and nine German startups participated in the German American Chamber of Commerce (GACC) to meet investors at pitches in New York and San Francisco targeted to support our entry into the US market.

At the congress 'Anonymization for Secure Data Usage', leading branches heads came together in Lübeck from April 16th to 17th, 2024, to present and discuss the latest findings and innovative approaches to data anonymization.

We're thrilled to have experienced such a great turnout and interest at the ECR in Vienna last week! Once again, it's been confirmed that we're on the right track. Our major advantage is that we offer "Prostate.Carcinoma.ai" to our customers as fully integratable software.